Efficacy and safety of gastrointestinal bleeding prophylaxis in critically ill patients: systematic review and network meta-analysis
暂无分享,去创建一个
G. Guyatt | T. Agoritsas | A. Perner | L. Ge | P. Vandvik | R. Siemieniuk | M. Møller | Lihong Liu | Ying Wang | Z. Ye | Xin Wang | Liangying Hou | Zhuo Ma | Yingkai Wang | Ying Wang
[1] Gordon H Guyatt,et al. GRADE approach to rate the certainty from a network meta-analysis: addressing incoherence. , 2019, Journal of clinical epidemiology.
[2] J. Jakobsen,et al. Stress ulcer prophylaxis with proton pump inhibitors or histamin-2 receptor antagonists in adult intensive care patients: a systematic review with meta-analysis and trial sequential analysis , 2019, Intensive Care Medicine.
[3] Gordon H Guyatt,et al. GRADE approach to rate the certainty from a network meta-analysis: avoiding spurious judgments of imprecision in sparse networks. , 2019, Journal of clinical epidemiology.
[4] M. Wise,et al. Pantoprazole in Patients at Risk for Gastrointestinal Bleeding in the ICU , 2018, The New England journal of medicine.
[5] G. Guyatt,et al. Prophylaxis against Upper Gastrointestinal Bleeding in Hospitalized Patients. , 2018, The New England journal of medicine.
[6] H. Khalili,et al. Comparing efficacy of enteral nutrition plus ranitidine and enteral nutrition alone as stress ulcer prophylaxis. , 2018, Journal of comparative effectiveness research.
[7] Y. Xia,et al. Prevention of upper gastrointestinal bleeding in critically ill Chinese patients: a randomized, double-blind study evaluating esomeprazole and cimetidine , 2018, Current medical research and opinion.
[8] T. Wiemken,et al. Enteral nutrition as stress ulcer prophylaxis in critically ill patients: A randomized controlled exploratory study , 2018, Journal of critical care.
[9] B. Du,et al. Stress ulcer prophylaxis in intensive care unit patients receiving enteral nutrition: a systematic review and meta-analysis , 2018, Critical Care.
[10] Interventions for preventing upper gastrointestinal bleeding in people admitted to intensive care units. , 2010, The Cochrane database of systematic reviews.
[11] Gordon H Guyatt,et al. Advances in the GRADE approach to rate the certainty in estimates from a network meta-analysis. , 2018, Journal of clinical epidemiology.
[12] G. Guyatt,et al. Efficacy and safety of stress ulcer prophylaxis in critically ill patients: a network meta-analysis of randomized trials , 2017, Intensive Care Medicine.
[13] G. Guyatt,et al. Withholding Pantoprazole for Stress Ulcer Prophylaxis in Critically Ill Patients: A Pilot Randomized Clinical Trial and Meta-Analysis* , 2017, Critical care medicine.
[14] C. Rayner,et al. Pantoprazole or Placebo for Stress Ulcer Prophylaxis (POP-UP): Randomized Double-Blind Exploratory Study* , 2016, Critical care medicine.
[15] Gordon H Guyatt,et al. Introduction to BMJ Rapid Recommendations , 2016, British Medical Journal.
[16] G. Guyatt,et al. Efficacy and safety of proton pump inhibitors for stress ulcer prophylaxis in critically ill patients: a systematic review and meta-analysis of randomized trials , 2016, Critical Care.
[17] Nicky J Welton,et al. Automated generation of node‐splitting models for assessment of inconsistency in network meta‐analysis , 2015, Research synthesis methods.
[18] Tzong-Hsi Lee,et al. Stress ulcer prophylaxis in patients being weaned from the ventilator in a respiratory care center: A randomized control trial. , 2016, Journal of the Formosan Medical Association = Taiwan yi zhi.
[19] D. Cook,et al. Stress ulcer prophylaxis in the intensive care unit: an international survey of 97 units in 11 countries , 2015, Acta anaesthesiologica Scandinavica.
[20] D. Cook,et al. Prevalence and outcome of gastrointestinal bleeding and use of acid suppressants in acutely ill adult intensive care patients , 2015, Intensive Care Medicine.
[21] B. Erstad,et al. Pharmacoepidemiology of stress ulcer prophylaxis in the United States and Canada. , 2014, Journal of critical care.
[22] Mohammad Hassan Murad,et al. A GRADE Working Group approach for rating the quality of treatment effect estimates from network meta-analysis , 2014, BMJ : British Medical Journal.
[23] T. Luedde,et al. Administration of proton pump inhibitors in critically ill medical patients is associated with increased risk of developing Clostridium difficile-associated diarrhea. , 2014, Journal of critical care.
[24] Lin-Hsue Yang,et al. Comparison of the efficacy of esomeprazole and famotidine against stress ulcers in a neurosurgical intensive care unit , 2014 .
[25] S. Abbasi,et al. The comparison between proton pump inhibitors and sucralfate in incidence of ventilator associated pneumonia in critically ill patients , 2014, Advanced biomedical research.
[26] H. Cohen,et al. 731: IV Famotidine vs. IV Pantoprazole for Stress Ulcer Prevention in the ICU , 2013 .
[27] Panagiota Spyridonos,et al. Graphical Tools for Network Meta-Analysis in STATA , 2013, PloS one.
[28] J. Fogas,et al. Effects of proton pump inhibitor versus H2-receptor antagonist stress ulcer prophylaxis on ventilator-associated pneumonia: a pilot study , 2013, Critical Care.
[29] Alex J. Sutton,et al. Evidence Synthesis for Decision Making 2: A Generalized Linear Modeling Framework for Pairwise and Network Meta-analysis of Randomized Controlled Trials. , 2013 .
[30] B. Li,et al. A randomized controlled study comparing omeprazole and cimetidine for the prophylaxis of stress-related upper gastrointestinal bleeding in patients with intracerebral hemorrhage. , 2013, Journal of neurosurgery.
[31] S. Torabian,et al. Effects of Ranitidine and Pantoprazole on Ventilator-Associated Pneumonia: A Randomized Double-Blind Clinical Trial , 2013, Tanaffos.
[32] Anna Chaimani,et al. Using network meta‐analysis to evaluate the existence of small‐study effects in a network of interventions , 2012, Research synthesis methods.
[33] Gerald Gartlehner,et al. [GRADE guidelines: 8. Rating the quality of evidence - indirectness]. , 2012, Zeitschrift fur Evidenz, Fortbildung und Qualitat im Gesundheitswesen.
[34] Gerald Gartlehner,et al. [GRADE guidelines: 7. Rating the quality of evidence - inconsistency]. , 2012, Zeitschrift fur Evidenz, Fortbildung und Qualitat im Gesundheitswesen.
[35] M. Sculpher,et al. Bayesian methods for evidence synthesis in cost-effectiveness analysis , 2012, PharmacoEconomics.
[36] G. Guyatt,et al. GRADE guidelines: 8. Rating the quality of evidence--indirectness. , 2011, Journal of clinical epidemiology.
[37] Gordon H Guyatt,et al. GRADE guidelines: 7. Rating the quality of evidence--inconsistency. , 2011, Journal of clinical epidemiology.
[38] G. Guyatt,et al. GRADE guidelines 6. Rating the quality of evidence--imprecision. , 2011, Journal of clinical epidemiology.
[39] Gordon H Guyatt,et al. GRADE guidelines: 5. Rating the quality of evidence--publication bias. , 2011, Journal of clinical epidemiology.
[40] Howard Balshem,et al. GRADE guidelines: 3. Rating the quality of evidence. , 2011, Journal of clinical epidemiology.
[41] G. Guyatt,et al. GRADE guidelines: 4. Rating the quality of evidence--study limitations (risk of bias). , 2011, Journal of clinical epidemiology.
[42] J. Higgins. Cochrane handbook for systematic reviews of interventions. Version 5.1.0 [updated March 2011]. The Cochrane Collaboration , 2011 .
[43] F. Gao,et al. Effect of histamine-2-receptor antagonists versus sucralfate on stress ulcer prophylaxis in mechanically ventilated patients: a meta-analysis of 10 randomized controlled trials , 2010, Critical care.
[44] G. Brophy,et al. Prospective, Randomized Comparison of Lansoprazole Suspension, and Intermittent Intravenous Famotidine on Gastric pH and Acid Production in Critically ill Neurosurgical Patients , 2010, Neurocritical care.
[45] Ravinder D Bhanot. Nosocomial Pneumonia In Mechanically Ventilated Patients Receiving Ranitidine, Omeprazole or Sucralfate As Stress Ulcer Prophylaxis , 2010, ATS 2010.
[46] Xin Sun,et al. Is a subgroup effect believable? Updating criteria to evaluate the credibility of subgroup analyses , 2010, BMJ : British Medical Journal.
[47] Michael D Howell,et al. Acid-suppressive medication use and the risk for hospital-acquired pneumonia. , 2009, JAMA.
[48] M. Kouchak,et al. Comparison between the preventive effects of ranitidine and omeprazole on upper gastrointestinal bleeding among ICU patients. , 2009 .
[49] M. Mokhtari,et al. Ventilator-associated pneumonia among ICU patients receiving mechanical ventilation and prophylaxis of gastrointestinal bleeding , 2009 .
[50] J. Graepel,et al. Intermittent intravenous pantoprazole and continuous cimetidine infusion: effect on gastric pH control in critically ill patients at risk of developing stress-related mucosal disease. , 2008, The Journal of trauma.
[51] G. Guyatt,et al. GRADE: an emerging consensus on rating quality of evidence and strength of recommendations , 2008, BMJ : British Medical Journal.
[52] S. Prakash,et al. Nosocomial Pneumonia in Mechanically Ventilated Patients Receiving Ranitidine or Sucralfate as Stress Ulcer Prophylaxis , 2008 .
[53] N. Sut,et al. Effect of Proton Pump Inhibitors on Gastric Juice Volume, Gastric pH and Gastric Intramucosal pH in Critically Ill Patients , 2008, Clinical drug investigation.
[54] R. Bagin,et al. Randomized, double-blind comparison of immediate-release omeprazole oral suspension versus intravenous cimetidine for the prevention of upper gastrointestinal bleeding in critically ill patients , 2005, Critical care medicine.
[55] Lack of effect of ranitidine on gastric luminal pH and mucosal PCO2 during the first day in the ICU , 2005, Acta anaesthesiologica Scandinavica.
[56] C. Metz,et al. Effect of ranitidine on intragastric pH and stress-related upper gastrointestinal bleeding in patients with severe head injury , 1995, Digestive Diseases and Sciences.
[57] İ. Köksal,et al. Acute stress bleeding prophylaxis with sucralfate versus ranitidine and incidence of secondary pneumonia in intensive care unit patients , 1995, Intensive Care Medicine.
[58] Dagmar Řehořková,et al. Stress ulcer prophylaxis in critically ill patients: a randomized controlled trial. , 2004, Hepato-gastroenterology.
[59] M. Levy,et al. Comparison of Omeprazole and Ranitidine for Stress Ulcer Prophylaxis , 1997, Digestive Diseases and Sciences.
[60] S. Xin. The Preventive Effects of Rabeprazole on Upper Gastrointestinal Tract Hemorrhage in Patients with Severe Acute Pancr eatitis , 2004 .
[61] V. Darlong,et al. Stress ulcer prophylaxis in patients on ventilator. , 2003, Tropical gastroenterology : official journal of the Digestive Diseases Foundation.
[62] M. Fink,et al. Intravenous pantoprazole (IVP) and continuous infusion cimetidine (C) prevent upper gastrointestinal bleeding (UGIB) regardless of APSII score (APACHE II) in high risk intensive care unit (ICU) patients , 2003 .
[63] T. Lumley. Network meta‐analysis for indirect treatment comparisons , 2002, Statistics in medicine.
[64] A. Sheiham,et al. Fluoride gels for preventing dental caries in children and adolescents. , 2002, The Cochrane database of systematic reviews.
[65] Gordon H Guyatt,et al. The attributable mortality and length of intensive care unit stay of clinically important gastrointestinal bleeding in critically ill patients , 2001, Critical care.
[66] Avid,et al. A COMPARISON OF SUCRALFATE AND RANITIDINE FOR THE PREVENTION OF UPPER GASTROINTESTINAL BLEEDING IN PATIENTS REQUIRING MECHANICAL VENTILATION , 2001 .
[67] A. Sood,et al. A comparative study of the effects of famotidine and sucralfate in prevention of upper gastro-intestinal bleeding in patients of head injury , 2000 .
[68] G. Palácio,et al. PREVENTION OF SRESS ULCER BLEEDING IN HIGH RISK PATIENTS. COMPARISON OF THREE DRUGS. , 1999 .
[69] E. Hanisch,et al. A randomized, double-blind trial for stress ulcer prophylaxis shows no evidence of increased pneumonia. , 1998, American journal of surgery.
[70] G. Guyatt,et al. A comparison of sucralfate and ranitidine for the prevention of upper gastrointestinal bleeding in patients requiring mechanical ventilation. Canadian Critical Care Trials Group. , 1998, The New England journal of medicine.
[71] R. Huckfeldt,et al. A MULTICENTER, PROSPECTIVE, RANDOMIZED CLINICAL TRIAL OF CONTINUOUS INFUSION I.V. RANITIDINE VS. OMEPRAZOLE SUSPENSION IN THE PROPHYLAXIS OF STRESS ULCERS , 1998 .
[72] G. Smith,et al. Bias in meta-analysis detected by a simple, graphical test , 1997, BMJ.
[73] H. Norton,et al. Nosocomial pneumonia in ventilated trauma patients during stress ulcer prophylaxis with sucralfate, antacid, and ranitidine. , 1996, The Journal of trauma.
[74] E. Lai,et al. Prospective double-blind placebo-controlled randomized trial on the use of ranitidine in preventing postoperative gastroduodenal complications in high-risk neurosurgical patients. , 1995, Journal of neurosurgery.
[75] H. Spapen,et al. One week treatment with cimetidine does not attenuate the cortisol response to a short corticotropin test in stable intensive care patients: a prospective, randomized, and controlled study. , 1995, Acta anaesthesiologica Belgica.
[76] J. Eddleston,et al. Prospective endoscopic study of stress erosions and ulcers in critically ill adult patients treated with either sucralfate or placebo , 1994, Critical care medicine.
[77] G. Divine,et al. Prophylaxis for Stress-related Gastric Hemorrhage in the Medical Intensive Care Unit , 1994, Annals of Internal Medicine.
[78] P. Francioli,et al. Nosocomial Pneumonia in Mechanically Ventilated Patients Receiving Antacid, Ranitidine, or Sucralfate as Prophylaxis for Stress Ulcer , 1994, Annals of Internal Medicine.
[79] C. Metz,et al. Impact of multiple risk factors and ranitidine prophylaxis on the development of stress‐related upper gastrointestinal bleeding: A prospective, multicenter, double‐blind, randomized trial , 1993 .
[80] R. Falcone,et al. Occurrence of nosocomial pneumonia in mechanically ventilated trauma patients: A comparison of sucralfate and ranitidine , 1993, Critical care medicine.
[81] D. Teres,et al. Nosocomial pneumonia during stress ulcer prophylaxis with cimetidine and sucralfate. , 1993, Archives of surgery.
[82] T. Fabian,et al. Pneumonia and stress ulceration in severely injured patients. A prospective evaluation of the effects of stress ulcer prophylaxis. , 1993, Archives of surgery.
[83] F. Rockhold,et al. Continuous intravenous cimetidine decreases stress‐related upper gastrointestinal hemorrhage without promoting pneumonia , 1993, Critical care medicine.
[84] G. Bhave,et al. Gastric colonization and pneumonia in intubated critically ill patients receiving stress ulcer prophylaxis: A randomized, controlled trial , 1992, Critical Care Medicine.
[85] J. Manzano,et al. Stress‐induced gastroduodenal lesions and total parenteral nutrition in critically ill patients: Frequency, complications, and the value of prophylactic treatment. A prospective, randomized study , 1991, Critical care medicine.
[86] E. DeMaria,et al. Role of gastric colonization in the development of pneumonia in critically ill trauma patients: results of a prospective randomized trial. , 1990, The Journal of trauma.
[87] W. Zimmerli,et al. Prospective endoscopic study of stress erosions and ulcers in critically ill neurosurgical patients: current incidence and effect of acid-reducing prophylaxis. , 1990, Critical care medicine.
[88] F. Rockhold,et al. Comparison of Cimetidine and Placebo for the Prophylaxis of Upper Gastrointestinal Bleeding Due to Stress-related Gastric Mucosal Damage in the Intensive Care Unit , 1990 .
[89] H. Kehlet,et al. Ranitidine for improvement of delayed hypersensitivity response in patients with sepsis. , 1989, Acta chirurgica Scandinavica.
[90] B. Schneeweiss,et al. Prevention of upper gastrointestinal bleeding in long-term ventilated patients. Sucralfate versus ranitidine. , 1989, The American journal of medicine.
[91] S. Davies,et al. Use of isradipine in hypertension following coronary artery bypass surgery. , 1989, The American journal of medicine.
[92] B. Schneeweiss,et al. [Prevention of stress hemorrhage in an internal medicine intensive care station: sucralfate versus ranitidine]. , 1988, Der Anaesthesist.
[93] J. Jones,et al. Prophylaxis of upper gastrointestinal tract bleeding in mechanically ventilated patients. A randomized study comparing the efficacy of sucralfate, cimetidine, and antacids. , 1987, Archives of internal medicine.
[94] R. Wigle,et al. Cimetidine prophylaxis for gastrointestinal bleeding in an intensive care unit. , 1986, Gut.
[95] M. Laxenaire,et al. Ranitidine pour la prophylaxie de l'ulcère de stress chez les traumatisés crâniens graves , 1986 .
[96] M. Tryba,et al. Prevention of acute stress bleeding with sucralfate, antacids, or cimetidine. A controlled study with pirenzepine as a basic medication. , 1985, The American journal of medicine.
[97] L. Johnson,et al. Cimetidine for prevention and treatment of gastroduodenal mucosal lesions in patients in an intensive care unit. , 1985, Annals of internal medicine.
[98] B. Berg,et al. Prevention of stress-induced upper gastrointestinal bleeding by cimetidine in patients on assisted ventilation. , 1985 .
[99] B. van den Berg,et al. Prevention of stress-induced upper gastrointestinal bleeding by cimetidine in patients on assisted ventilation. , 1985, Digestion.
[100] P. Suratt,et al. Prophylaxis of upper gastrointestinal hemorrhage in patients requiring mechanical ventilation , 1982, Critical care medicine.
[101] N. Basso,et al. Cimetidine and antacid prophylaxis of acute upper gastrointestinal bleeding in high risk patients. Controlled, randomized trial. , 1981, American journal of surgery.
[102] M. Zinner,et al. The prevention of upper gastrointestinal tract bleeding in patients in an intensive care unit. , 1981, Surgery, gynecology & obstetrics.
[103] J. Miller,et al. Prevention of acute gastrointestinal complications after severe head injury: a controlled trial of cimetidine prophylaxis. , 1980, American journal of surgery.
[104] R. Bailey,et al. H2-RECEPTOR ANTAGONISTS AND ANTACIDS IN THE PREVENTION OF ACUTE GASTROINTESTINAL HÆMORRHAGE IN FULMINANT HEPATIC FAILURE Two Controlled Trials , 1977, The Lancet.